1-10 of 10
Silvia Peola
Close
Sort by
Journal Articles

Identifying Novel Mechanisms of Resistance to Tyrosine Kinase Inhibitors in Anaplastic Large Cell Lymphoma

Elif Atabay, PhD, Qi Wang, PhD, Ambrogio Chiara, PhD, Taek-Chin Cheong, PhD, Silvia Peola, Geeta G Sharma, PhD, Luca Mologni, PhD, Carlo Gambacorti-Passerini, MD, Claudia Voena, PhD, Roberto Chiarle, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5060.
https://doi.org/10.1182/blood-2019-132188
Published: 2019
Journal Articles

Dysfunctional Vγ9Vδ2 T cells are negative prognosticators and markers of dysregulated mevalonate pathway activity in chronic lymphocytic leukemia cells

Marta Coscia, Candida Vitale, Silvia Peola, Myriam Foglietta, Micol Rigoni, Valentina Griggio, Barbara Castella, Daniela Angelini, Sabina Chiaretti, Chiara Riganti, Anna Guarini, Daniela Drandi, Marco Ladetto, Amalia Bosia, Robin Foà, Luca Battistini, Mario Boccadoro, Jean-Jacques Fournié, Massimo Massaia
Journal: Blood
Blood (2012) 120 (16): 3271–3279.
https://doi.org/10.1182/blood-2012-03-417519
Published: 2012
Includes: Supplemental data
Journal Articles

The Mevalonate Pathway As a Metabolic Target to Circumvent Multidrug-Resistance in Chronic Lymphocytic Leukemia Cells

Marta Coscia, MD, PhD, Micol Rigoni, PhD, Chiara Riganti, MD, Ivana Campia, PhD, Candida Vitale, MD, Valentina Griggio, PhD, Silvia Peola, PhD, Barbara Castella, PhD, Patrizia Sciancalepore, MD, Daniela Drandi, PhD, Marco Ladetto, MD, Amalia Bosia, MD, Mario Boccadoro, MD, Massimo Massaia, MD
Journal: Blood
Blood (2011) 118 (21): 735.
https://doi.org/10.1182/blood.V118.21.735.735
Published: 2011
Journal Articles

Identification by Serological Proteome Analysis (SERPA) of Tumor-Associated Antigens Eliciting Antibody Responses In Chronic Lymphocytic Leukemia (CLL)

Marta Coscia, MD, PhD, Michela Capello, PhD, Valentina Griggio, PhD, Federica Linty, PhD, Candida Vitale, MD, Silvia Peola, PhD, Barbara Castella, PhD, Micol Rigoni, PhD, Daniela Drandi, PhD, Marina Ruggeri, PhD, Paola Omedè, PhD, Marco Ladetto, MD, Franco Novelli, MD, Mario Boccadoro, MD, Massimo Massaia, MD
Journal: Blood
Blood (2010) 116 (21): 917.
https://doi.org/10.1182/blood.V116.21.917.917
Published: 2010
Journal Articles

The Defective Proliferation of Vgamma9Vdelta2 T Cells to Zoledronic Acid In Chronic Lymphocytic Leukemia (CLL) Is a Powerful Time to First Treatment (TFT) Predictor Associated with the IGHV Mutational Status

Marta Coscia, MD, PhD, Candida Vitale, MD, Silvia Peola, PhD, Chiara Riganti, MD, Daniela Angelini, PhD, Myriam Foglietta, MD, Francesca Pantaleoni, PhD, Giorgia Matta, MD, Sabina Chiaretti, MD, Anna Guarini, PhD, Daniela Drandi, PhD, Marco Ladetto, MD, Amalia Bosia, MD, Luca Battistini, MD, Robin Foà, MD, Mario Boccadoro, MD, Jean-Jacques Fournié, PhD, Massimo Massaia, MD
Journal: Blood
Blood (2010) 116 (21): 3602.
https://doi.org/10.1182/blood.V116.21.3602.3602
Published: 2010
Journal Articles

IGHV Unmutated Chronic Lymphocytic Leukemia (CLL) B Cells Are More Susceptible to Spontaneous Apoptosis Than Mutated CLL B Cells and Are Subject to the Anti-Apoptotic Effect of Environmental Signals

Marta Coscia, MD, PhD, Francesca Pantaleoni, PhD, Chiara Riganti, MD, Candida Vitale, MD, Micol Rigoni, PhD, Silvia Peola, PhD, Daniela Drandi, PhD, Barbara Castella, PhD, Marina Ruggeri, PhD, Paola Omedè, MD, Marco Ladetto, MD, Amalia Bosia, MD, Mario Boccadoro, MD, Massimo Massaia, MD
Journal: Blood
Blood (2010) 116 (21): 2431.
https://doi.org/10.1182/blood.V116.21.2431.2431
Published: 2010
Journal Articles

Differential Effects of Microenvironmental Elements On Tumor Cells Survival in Chronic Lymphocytic Leukemia Patient Subsets with Good or Poor Prognosis.

Marta Coscia, MD, Francesca Pantaleoni, PhD, Chiara Riganti, MD, Micol Rigoni, PhD, Candida Vitale, MD, Silvia Peola, PhD, Daniela Drandi, Marco Ladetto, Amalia Bosia, MD, Mario Boccadoro, Massimo Massaia, MD
Journal: Blood
Blood (2009) 114 (22): 2333.
https://doi.org/10.1182/blood.V114.22.2333.2333
Published: 2009
Journal Articles

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams, Giulia Costa, Ilaria Tamagno, Dario Ferrero, Valentina Giai, Marta Coscia, Silvia Peola, Massimo Massaia, Gabriella Pezzoni, Cecilia Allievi, Nicoletta Pescalli, Mara Cassin, Stefano di Giovine, Paola Nicoli, Paola de Feudis, Ivan Strepponi, Ilaria Roato, Riccardo Ferracini, Benedetta Bussolati, Giovanni Camussi, Susan Jones-Bolin, Kathryn Hunter, Hugh Zhao, Antonino Neri, Antonio Palumbo, Celia Berkers, Huib Ovaa, Alberto Bernareggi, Giorgio Inghirami
Journal: Blood
Blood (2008) 111 (5): 2765–2775.
https://doi.org/10.1182/blood-2007-07-100651
Published: 2008
Journal Articles

Phenotypic and Functional Features of Vγ9/Vδ2 T Cells in Chronic Lymphocytic Leukemia Are Strongly Correlated with the Mutational Status of the Immunoglobulin Heavy Chain Variable Region (IgVH) and Metabolic Activity of the Mevalonate Pathway in Tumor Cells.

Marta Coscia, MD, Silvia Peola, PhD, Giorgia Matta, MD, Francesca Pantaleoni, PhD, Myriam Foglietta, MD, Daniela Angelini, PhD, Sabina Chiaretti, MD, Chiara Riganti, MD, Anna Guarini, PhD, Daniela Drandi, PhD, Marco Ladetto, MD, Amalia Bosia, MD, Robin Foà, MD, Luca Battistini, MD, Mario Boccadoro, MD, Jean Jacques Fournie, PhD, Massimo Massaia, MD
Journal: Blood
Blood (2007) 110 (11): 1131.
https://doi.org/10.1182/blood.V110.11.1131.1131
Published: 2007
Journal Articles

Idiotype Vaccination in Human Myeloma: Generation of Tumor-Specific Immune Responses After High-Dose Chemotherapy

Massimo Massaia, Paolo Borrione, Silvano Battaglio, Sara Mariani, Eloise Beggiato, Patrizia Napoli, Claudia Voena, Alberto Bianchi, Marta Coscia, Barbara Besostri, Silvia Peola, Thomas Stiefel, Jos Even, Domenico Novero, Mario Boccadoro, Alessandro Pileri
Journal: Blood
Blood (1999) 94 (2): 673–683.
https://doi.org/10.1182/blood.V94.2.673
Published: 1999